Article info
PDFTherapeutics/Prevention
Randomized clinical trial
Detemir is non-inferior to NPH insulin in women with pregestational type 2 diabetes and gestational diabetes mellitus
- Correspondence to : Dr Guillermo Umpierrez, Division of Endocrinology, Metabolism and Lipids, Emory University School of Medicine, 49 Jesse Hill Jr. Dr. SE, Atlanta, GA 30308, USA; geumpie{at}emory.edu
Citation
Detemir is non-inferior to NPH insulin in women with pregestational type 2 diabetes and gestational diabetes mellitus
Publication history
- First published February 3, 2016.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/